For startups, getting a drug to market is a marathon but founders need to think beyond filing patents to win over investors, ...

Disputed drug forms part of a multi-billion dollar franchise for J&J, ranking among its largest revenue drivers in mental ...

LSPN panellists from Mathys & Squire discuss recent developments affecting the EPO Boards of Appeal and decisions emerging ...

4 February 2025 LSIPR sister title WIPR releases USA Patents Rankings, divided into categories of non-contentious and ...

California medical device company sues rival at the ITC and in Delaware court over “copycat” brain monitoring system launch in May | Ceribell accuses competitor of “a history of willful patent ...

German and Finnish pharma giants sue Indian rival in Delaware court | Dispute centres on generic bid for prostate cancer ...

Office declined application, citing earlier authorisations for inhalers designed for people containing the same ingredient | Boehringer argued that ciclesonide was a ‘new active substance’ not ...

New addition expected to strengthen firm’s foundational ‘IP’ practice. If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, ...

Biocon failed to provide critical information about proposed denosumab product, Amgen claims | Company expects ‘sales erosion ...

Judge says sale of genetic data is ‘scary proposition’ but that blanket ban could result in missed opportunities | Former CEO ...

8 November 2017 Generic drugs maker Accord Healthcare has lost a battle to have a patent invalidated at the English High ...

26 June 2025 Insurance company Cigna claims Bristol Myers Squibb may have caused overpayments of ‘billions’ of dollars after ...